The Global Burden of Disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease?

Degenhardt, Louisa, Whiteford, Harvey and Hall, Wayne D. (2014) The Global Burden of Disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease?. Drug and Alcohol Review, 33 1: 4-12. doi:10.1111/dar.12088


Author Degenhardt, Louisa
Whiteford, Harvey
Hall, Wayne D.
Title The Global Burden of Disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease?
Journal name Drug and Alcohol Review   Check publisher's open access policy
ISSN 0959-5236
1465-3362
Publication date 2014-01
Year available 2013
Sub-type Article (original research)
DOI 10.1111/dar.12088
Open Access Status DOI
Volume 33
Issue 1
Start page 4
End page 12
Total pages 9
Place of publication Chichester, West Sussex, United Kingdom
Publisher Wiley-Blackwell Publishing
Collection year 2014
Language eng
Formatted abstract
Introduction The Global Burden of Disease (GBD) 2010 study updated the findings of earlier exercises. It provided regional and global estimates of the burden of disease attributable to diseases, injuries and risk factors. Here we provide a brief summary of the work for illicit drug use.

Design Systematic reviews were undertaken to estimate the major epidemiological parameters (incidence, prevalence, duration/remission and mortality) for each drug. Reviews evaluated the nature and quality of evidence for illicit drug use as a risk factor for many health outcomes, for the comparative risk assessment (CRA) exercise.

Results Substantial gaps existed in basic epidemiological parameters. Following modelling and imputation of missing data, it was estimated that opioid and amphetamine dependence were the most common forms of illicit drug dependence in 2010; opioid dependence was responsible for the greatest burden. Few putative consequences of illicit drug use had the quality or quantity of data required to be included in the CRA.

Discussion Estimates of the extent and distribution of disease burden are likely to shape global and regional health policy development. The GBD exercise will be repeated on an annual basis; GBD 2010 clearly demonstrated that although the illicit drug field is generating more and better epidemiological data on the health risks of drug use, there is still much work to be done to generate defensible estimates of the magnitude of risk, particularly for impactful and prevalent outcomes, such as injuries, violence and mental health complications. Until then, burden of disease attributable to illicit drugs will be underestimated.
Keyword Illicit drugs
Dependence
Burden of disease
Epidemiology
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ
Additional Notes Article first published online: 20 NOV 2013

 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 17 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 19 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Thu, 13 Feb 2014, 14:37:50 EST by Roheen Gill on behalf of Queensland Brain Institute